Plant Health Care PLC
01 October 2007
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):
PLANT HEALTH CARE plc
2. Reason for the notification (please state Yes/No): ( )
An acquisition or disposal of voting rights: (YES)
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify): ()
3. Full name of person(s) subject to the notification obligation (iii):
Credit Suisse Securities (Europe) Limited
4. Full name of shareholder(s) (if different from 3.) (iv):
5. Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):
27 September 2007
6. Date on which issuer notified:
01 October 2007
7. Threshold(s) that is/are crossed or reached:
3%
8. Notified details:
A: Voting rights attached to shares
Class/type of shares if Situation previous to the Triggering transaction (vi)
possible using the ISIN
CODE
Number of Number of
shares voting Rights
(viii)
GB00B01JC540
Resulting situation after the triggering transaction (vii)
Class/type of Number of Number of voting rights (ix) % of voting rights
shares if shares
possible using
the ISIN CODE
Direct Direct (x) Indirect (xi) Direct Indirect
GB00B01JC540 1,270,932 1,270,932 N/A 3.02% N/A
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Exercise/ Number of voting rights that may % of
financial Date Conversion be acquired if the instrument is voting
instrument (xiii) Period/Date exercised/ converted. rights
(xiv)
Total (A+B)
Number of % of voting
voting rights rights
1,270,932 3.02%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):
Credit Suisse Securities (Europe) Limited and Credit Suisse International are
part of the Investment Banking division of Credit Suisse ('CSIBD'), which is
part of the Credit Suisse Group ('CSG'). CSIBD is a segregated business unit
within CSG with an independent management structure and exercises its voting
rights independently from other divsions of CSG
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:
(i) Andrew Wood FCIS, Company Secretary
(II) Tim Redfern, Evolution Securities Limited
(iii) Jeremy Carey, Tavistock Communications
15. Contact telephone number:
(i) +44 (0)20 8866 5702
(ii) +44 (0)20 7071 4312
(iii) +44 (0)20 7920 3150
Annex to Notification Of Major Interests In Shares (xvi)
A: Identity of the person or legal entity subject to the notification obligation
Full name (including legal form for legal entities):
Credit Suisse Securities (Europe) Limited
Contact address (registered office for legal entities):
1 Cabot Square, Canary Wharf, London E14 4QJ
Phone number:
+44 (0)20 7888 5416
Other useful information (at least legal representative for legal persons):
William Dawson
B: Identity of the notifier, if applicable (xvii)
Full name:
Contact address:
Phone number:
Other useful information (e.g. functional relationship with the person or legal
entity subject to the notification obligation)
END
01 October 2007
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.